首页> 美国卫生研究院文献>International Journal of Endocrinology >Activation of Toll-Like Receptors and Inflammasome Complexes in the Diabetic Cardiomyopathy-Associated Inflammation
【2h】

Activation of Toll-Like Receptors and Inflammasome Complexes in the Diabetic Cardiomyopathy-Associated Inflammation

机译:糖尿病性心肌病相关炎症中类似收费受体和炎性体复合物的激活。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diabetic cardiomyopathy is defined as a ventricular dysfunction initiated by alterations in cardiac energy substrates in the absence of coronary artery disease and hypertension. Hyperglycemia, hyperlipidemia, and insulin resistance are major inducers of the chronic low-grade inflammatory state that characterizes the diabetic heart. Cardiac Toll-like receptors and inflammasome complexes may be key inducers for inflammation probably through NF-κB activation and ROS overproduction. However, metabolic dysregulated factors such as peroxisome proliferator-activated receptors and sirtuins may serve as therapeutic targets to control this response by mitigating both Toll-like receptors and inflammasome signaling.
机译:糖尿病性心肌病定义为在没有冠心病和高血压的情况下由心脏能量底物的改变引发的心室功能障碍。高血糖症,高脂血症和胰岛素抵抗是糖尿病性心脏特征性慢性低度炎症状态的主要诱因。心脏Toll样受体和炎症小体复合物可能是炎症的主要诱因,可能是通过NF-κB活化和ROS过量产生引起的。但是,新陈代谢失调的因子,例如过氧化物酶体增殖物激活的受体和沉默调节蛋白可能通过减轻Toll样受体和炎性体信号传导而成为控制该反应的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号